AI & Tech··1 sources verified
Isomorphic Labs Raises $5B to Move AI-Designed Drug Candidates Into Clinical Trials
Summarised by Relevant News AI · Read time: 3 min
Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round. The company plans to use the funding to advance its drug candidates into clinical trials.
Why it matters: The size of this round signals that investors now see AI-driven drug discovery as capable of reaching human testing, a key test of whether AI can deliver real pharmaceutical pipelines.
All sources